Picture of Catalyst Pharmaceuticals logo

CPRX — Catalyst Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Brief: Catalyst Pharmaceuticals Q3 Revenue USD 148.4 Million Vs. IBES Estimate USD 136.8 Million

Nov 05 (Reuters) - Catalyst Pharmaceuticals Q3 adjusted net income USD 86.1 million.

Q3 net income USD 52.8 million

Q3 operating income USD 66.3 million

outlook FY revenue USD 565-585 million

Recent news on Catalyst Pharmaceuticals

See all news